The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study
INTRODUCTION: The curative treatment approach for diffuse large B-cell lymphoma (DLBCL) is controversial even in the rituximab (R) era. The aim of this study was to examine the FcγRIIIA gene polymorphism distribution of DLBCL patients who had been treated with R-CHOP (cyclophosphamide, doxorubi...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Turkish Society of Hematology
2015-05-01
|
| Serie: | Turkish Journal of Hematology |
| Soggetti: | |
| Accesso online: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-66587 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|